Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Angiogenesis. 2010 Sep 25;13(4):327–335. doi: 10.1007/s10456-010-9189-6

Figure 5.

Figure 5

NF-κB inhibition by Velcade leads to down-regulation of IL-6, uPAR, MCP-1 and MMP-1 in HemSCs. HemSCs treated with Velcade (5nM) were assayed by RT-qPCR for the mRNA expression of IL-6 (A), uPAR (B), MCP-1 (C) and MMP-1 (D). Dexamethasone (Dex) (200nM) served as a positive control.